Govt approved 746 applications till Nov under PLI schemes for different sectors including pharma

There has been a significant reduction in imports of raw materials in the pharma sector also.

Published On 2023-12-27 06:00 GMT | Update On 2023-12-27 13:04 GMT

New Delhi: As many as 746 applications have been approved till November 2023 under the Production Linked Incentive (PLI) schemes for 14 sectors such as pharma, white goods, and electronics, an official statement said on Tuesday. The schemes for 14 sectors were announced with an outlay of Rs 1.97 lakh crore to enhance India's manufacturing capabilities and exports.

The commerce and industry ministry said that beneficiary companies have set up units in more than 150 districts (24 states) and over Rs 95,000 crore of investment has been reported till September, which has led to production/sales of Rs 7.80 lakh crore and employment generation of over 6.4 lakh.

"746 applications have been approved till November 2023... Incentives worth around Rs 2,900 crores have been disbursed in 2022-23. There has been a value addition of 20 per cent in mobile manufacturing within a period of 3 years," the statement said.

It added that of the USD 101 billion worth of total electronics production in 2022-23, smartphones constituted USD 44 billion, including USD 11.1 billion as exports.

"Import substitution of 60 per cent has been achieved in the telecom sector and India has become almost self-reliant in Antennae, GPON (Gigabit Passive Optical Network) and CPE (Customer Premises Equipment)," the ministry said.

There has been a significant reduction in imports of raw materials in the pharma sector also.

"Unique intermediate materials and bulk drugs are being manufactured in India including Penicillin-G, and transfer of technology has happened in manufacturing of medical devices such as CT scan, MRI," it added.

About PLI in the white goods (AC and LED light components), it said that 64 companies have been selected under the scheme.

Out of this, 34 would invest Rs 5,429 crore for air conditioner components and 30 would invest Rs 1,337 crore for LED component manufacturing.

"Further investments of Rs 6,766 crore is envisaged creating additional direct employment of about 48,000 persons," the ministry said, adding 13 foreign companies are investing Rs 2,090 crore under the scheme.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Govt approved 746 applications till Nov under PLI schemes for different sectors including pharma

There has been a significant reduction in imports of raw materials in the pharma sector also.

Similar News

Innovent Biologics inks Global Strategic pact with Takeda to advance next generation IO, ADC cancer therapies

High-Alcohol Oral Drugs Over 12% to Come Under Prescription-Only H1 Category, Health Ministry Drafts Rules

Luxury Cars for Employees: This Pharma Firm's Diwali Giveaway Goes Viral

Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC

Beta Drugs' Methotrexate Oral Solution Gets SEC Manufacturing, Marketing Nod

USFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis

Torrent Pharma finally gets CCI nod for acquisition of JB Chemicals

Alembic Pharma gets USFDA okay for Triamcinolone Acetonide Injectable Suspension